LONGBIO-B (01779.HK): Shares included in eligible securities list under Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect

NewTimeSpace News: On 7 September 2026, LongBio Pharma (Suzhou) Co., Ltd. (stock code: 01779) voluntarily announced that, pursuant to the Notice on the Adjustment of Eligible Securities under Shanghai-Hong Kong Stock Connect issued by the Shanghai Stock Exchange on 4 September 2026 and the Announcement on the Adjustment of the Eligible Securities List under Shenzhen-Hong Kong Stock Connect issued by the Shenzhen Stock Exchange on 7 September 2026, the company had been included in the eligible securities lists under the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect schemes, effective from 7 September 2026.

Following the inclusion, eligible mainland Chinese investors will be able to buy and sell the company's shares directly through the Shanghai Stock Exchange and the Shenzhen Stock Exchange. The company expects the inclusion to help broaden its shareholder base, attract more long-term institutional investors and improve the trading liquidity of its shares, laying a solid foundation for its long-term development. The company will continue to focus on the discovery and development of biopharmaceuticals targeting allergic and autoimmune diseases.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.